Antibody-drug conjugates for multiple myeloma.

作者: Annabel McMillan , Dana Warcel , Rakesh Popat

DOI: 10.1080/14712598.2020.1802422

关键词: AntibodyCytotoxicityCancer researchMultiple myelomaDrugConjugateMyeloma cellMedicine

摘要: Introduction: Antibody drug conjugates (ADC) are a new class of treatment for multiple myeloma (MM) patients, delivering potent cytotoxic agent directly to the cell. The target is defined...

参考文章(82)
Sarah A. Laurent, Franziska S. Hoffmann, Peer-Hendrik Kuhn, Qingyu Cheng, Yuanyuan Chu, Marc Schmidt-Supprian, Stefanie M. Hauck, Elisabeth Schuh, Markus Krumbholz, Heike Rübsamen, Johanna Wanngren, Mohsen Khademi, Tomas Olsson, Tobias Alexander, Falk Hiepe, Hans-Walter Pfister, Frank Weber, Dieter Jenne, Hartmut Wekerle, Reinhard Hohlfeld, Stefan F. Lichtenthaler, Edgar Meinl, γ-secretase directly sheds the survival receptor BCMA from plasma cells Nature Communications. ,vol. 6, pp. 7333- 7333 ,(2015) , 10.1038/NCOMMS8333
Mohammad Tabrizi, Gadi Gazit Bornstein, Hamza Suria, Biodistribution mechanisms of therapeutic monoclonal antibodies in health and disease. Aaps Journal. ,vol. 12, pp. 33- 43 ,(2010) , 10.1208/S12248-009-9157-5
Yu-Tzu Tai, Patrick A. Mayes, Chirag Acharya, Mike Y. Zhong, Michele Cea, Antonia Cagnetta, Jenny Craigen, John Yates, Louise Gliddon, William Fieles, Bao Hoang, James Tunstead, Amanda L. Christie, Andrew L. Kung, Paul Richardson, Nikhil C. Munshi, Kenneth C. Anderson, Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma. Blood. ,vol. 123, pp. 3128- 3138 ,(2014) , 10.1182/BLOOD-2013-10-535088
Esther H Noordergraaf, Jolanda Gerritsen, Aran F Labrijn, Janine Schuurman, Patrick HC van Berkel, Paul WHI Parren, Michael J Gramer, Ewald TJ van den Bremer, Muriel D van Kampen, Amitava Kundu, Peter Kopfmann, Eric Etter, David Stinehelfer, Justin Long, Tom Lannom, Production of stable bispecific IgG1 by controlled Fab-arm exchange: Scalability from bench to large-scale manufacturing by application of standard approaches mAbs. ,vol. 5, pp. 962- 973 ,(2013) , 10.4161/MABS.26233
Eric Sanchez, Mingjie Li, Alex Kitto, Jennifer Li, Cathy S. Wang, Dylan T. Kirk, Ori Yellin, Cydney M. Nichols, Marissa P. Dreyer, Cameryn P. Ahles, Austin Robinson, Erik Madden, Gabriel N. Waterman, Regina A. Swift, Benjamin Bonavida, Ralph Boccia, Robert A. Vescio, John Crowley, Haiming Chen, James R. Berenson, Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival. British Journal of Haematology. ,vol. 158, pp. 727- 738 ,(2012) , 10.1111/J.1365-2141.2012.09241.X
Maureen C. Ryan, Michelle Hering, David Peckham, Charlotte F. McDonagh, Lindsay Brown, Kristine M. Kim, Damon L. Meyer, Roger F. Zabinski, Iqbal S. Grewal, Paul J. Carter, Antibody targeting of B-cell maturation antigen on malignant plasma cells Molecular Cancer Therapeutics. ,vol. 6, pp. 3009- 3018 ,(2007) , 10.1158/1535-7163.MCT-07-0464
Yu-Tzu Tai, Myles Dillon, Weihua Song, Merav Leiba, Xian-Feng Li, Peter Burger, Alfred I. Lee, Klaus Podar, Teru Hideshima, Audie G. Rice, Anne van Abbema, Lynne Jesaitis, Ingrid Caras, Debbie Law, Edie Weller, Wanling Xie, Paul Richardson, Nikhil C. Munshi, Claire Mathiot, Hervé Avet-Loiseau, Daniel E. H. Afar, Kenneth C. Anderson, Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu Blood. ,vol. 112, pp. 1329- 1337 ,(2008) , 10.1182/BLOOD-2007-08-107292
S Y Kristinsson, W F Anderson, O Landgren, Improved long-term survival in multiple myeloma up to the age of 80 years. Leukemia. ,vol. 28, pp. 1346- 1348 ,(2014) , 10.1038/LEU.2014.23
John Quinn, Janet Glassford, Laura Percy, Philippa Munson, Teresa Marafioti, Manuel Rodriguez-Justo, Kwee Yong, APRIL promotes cell-cycle progression in primary multiple myeloma cells: influence of D-type cyclin group and translocation status. Blood. ,vol. 117, pp. 890- 901 ,(2011) , 10.1182/BLOOD-2010-01-264424
Klaus Strebhardt, Axel Ullrich, Paul Ehrlich's magic bullet concept: 100 years of progress Nature Reviews Cancer. ,vol. 8, pp. 473- 480 ,(2008) , 10.1038/NRC2394